News

Keep up to date with us.

VelacurTM at AASLD’s The Liver Meeting 2020

Join Sonic Incytes at AASLD’s The Liver Meeting 2020, November 13-16, to find out more about how we’re creating accessible and affordable diagnostic solutions – with health insights you can count on – to improve patient care. Visit our booth and listen to our poster to learn about our breakthrough, point-of-care ultrasound solution, VelacurTM, for assessing and managing chronic liver disease.

Despite the rapidly increasing prevalence of fatty liver disease, many patients go undiagnosed, in large part due to the lack of an efficient diagnostic tool. VelacurTM is the first handheld 3D liver health assessment tool that is fast, accurate and intelligent. It provides consistently accurate results, enabling a clear picture of liver health in real time, so physicians can be confident in the diagnosis, treatment and care of their patients with all types of chronic liver disease.

Interested to find out more? Contact us at info@sonicincytes.com.